Literature DB >> 17021296

Measuring healthcare outcomes--a race to utopia?

Shahirose Jessani, Joseph Tomson.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17021296      PMCID： PMC1592062          DOI： 10.1177/014107680609901006

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  5 in total

Review 1.  Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Authors:  Lars Hjalmar Lindholm; Bo Carlberg; Ola Samuelsson
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

2.  The end of beta blockers for uncomplicated hypertension?

Authors:  D Gareth Beevers
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

3.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Authors: 
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

4.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

Review 5.  Payment by results or payment by outcome? The history of measuring medicine.

Authors:  Rory J O'Connor; Vera C Neumann
Journal:  J R Soc Med       Date:  2006-05       Impact factor: 18.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.